Page last updated: 2024-09-05

l 778,123 and idarubicin

l 778,123 has been researched along with idarubicin in 1 studies

Compound Research Comparison

Studies (l 778,123)	Trials (l 778,123)	Recent Studies (post-2010) (l 778,123)	Studies (idarubicin)	Trials (idarubicin)	Recent Studies (post-2010) (idarubicin)
23	3	2	1,795	454	487

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dallmann, I; Ganser, A; Morgan, MA; Onono, FO; Reuter, CW; Scherr, M; Spielmann, HP; Subramanian, T; Venturini, L	1

Other Studies

1 other study(ies) available for l 778,123 and idarubicin

Article	Year
Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells. Journal of molecular medicine (Berlin, Germany), 2012, Volume: 90, Issue:2 Topics: Anthracyclines; Antigens, Neoplasm; Apoptosis; Benzodiazepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dimethylallyltranstransferase; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Synergism; Farnesyltranstransferase; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Imidazoles; Leukemia, Myeloid; MAP Kinase Signaling System; Poly-ADP-Ribose Binding Proteins; Protein Prenylation	2012

Article

Year

Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.

Journal of molecular medicine (Berlin, Germany), 2012, Volume: 90, Issue:2

Topics: Anthracyclines; Antigens, Neoplasm; Apoptosis; Benzodiazepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dimethylallyltranstransferase; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Synergism; Farnesyltranstransferase; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Imidazoles; Leukemia, Myeloid; MAP Kinase Signaling System; Poly-ADP-Ribose Binding Proteins; Protein Prenylation

2012